Skip to main content
  • Oral presentation
  • Open access
  • Published:

Stress CMR as a gatekeeper to complete revascularisation in STEMI patients with moderate-severe bystander disease at primary percutaneous coronary intervention


Nearly 40% of the patients presenting with ST Elevation Myocardial Infarction (STEMI) have multivessel disease (MVD). Currently ESC and the ACC/AHA guidelines recommend revascularization of the culprit artery only. 2 recent trials (PRAMI and CVLPRIT) have shown a superiority of complete in-hospital revascularisation as compared to culprit only treatment. Although the mortality in the 2 groups in the trials were not significantly different but the composite end point was, which was mainly driven by ischaemia.


To assess the role of stress CMR as a gatekeeper to complete revascularisation in STEMI patients with moderate to severe bystander disease, treated with Primary PCI (PPCI) of the culprit lesion.


The study was performed from the data collected on consecutive patients who underwent PPCI between September 2011 - September 2013 at a tertiary centre in the South-West of England. A non-culprit lesion was considered to be moderate to severe if the stenosis was 50-75% in large proximal epicardial vessel or 70-90% elsewhere. Severe or critical bystander disease was excluded as the best treatment for those was deemed to be direct revascularisation without Fractional Flow reserve (FFR) assessment. The diagnostic accuracy of stress CMR was assumed 88% and FFR 100%. A simple cost analysis model was created with the data collected from stress CMR examinations and using the result in an FFR guided strategy. The United Kingdom or United States cost for each investigation used in the model is shown in table 1.

Table 1 Cost tariff


1,167 patients were included (74% males with a mean age 64 years). Significant MVD was present in 391 patients (33%). 157/391 (40%) underwent stress CMR guided approach. The remaining 234 patients either underwent direct revascularisation (presence of severe or critical stenosis) or underwent a stress echo guided treatment or died in hospital or were lost to follow up. Of those patients undergoing stress CMR, only 39% (61/157) had evidence of inducible myocardial perfusion defect. Putting these figures in a FFR guided approach model our study showed an average saving of £302 per patient or $1558 per patient in a UK based or US based cost assessment, respectively.


Our study demonstrated that, less than 40% patients undergoing PPCI with moderate to severe by-stander non-culprit coronary artery disease need further revascularisation. As a gatekeeper to complete revascularisation, stress CMR was also found to be a cheaper management strategy in a cost analysis model when UK or US-based costs were assumed.


This study was funded by the National Institute for Health Research Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dastidar, A.G., Carpenter, A., McAlindon, E. et al. Stress CMR as a gatekeeper to complete revascularisation in STEMI patients with moderate-severe bystander disease at primary percutaneous coronary intervention. J Cardiovasc Magn Reson 17 (Suppl 1), O29 (2015).

Download citation

  • Published:

  • DOI: